digital PCR

RainDance Technologies said this week that it has closed a structured debt financing with Capital Royalty Partners, providing it with up to $35 million to support the commercial expansion of its digital PCR and targeted DNA sequencing products.

Clinical researchers at Beth Israel Deaconess Medical Center and Harvard Medical School have teamed up with RainDance Technologies to explore the use of RainDance's picodroplet-based digital PCR platform to measure microRNA biomarkers in the blood of patients undergoing various c

A team led by researchers from the University of California, Berkeley, has developed a bead-based, microfluidic digital PCR technology and demonstrated its ability to quantitatively measure cancer-related translocation mutations at extremely low levels and subsequently sequence s

Trovagene is using RainDance Technologies' RainDrop Digital PCR system to develop and eventually run a cell-free transrenal BRAF mutation assay out of Trovagene's CLIA lab, the companies said this week.

A group of researchers from Massachusetts General Hospital has developed a method using either BEAMing RT-PCR or digital droplet-based PCR to detect mutations associated with glioblastoma brain tumors in RNA extracted from extracellular vesicles released from these tumors into pa

A research team led by Carl Hansen of the University of British Columbia's Centre for High-Throughput Biology has developed an integrated microfluidic device for high-throughput digital PCR analysis of single cells.

Scientists from Hungarian pharmaceutical development firm Avidin and the Hungarian Academy of Sciences have combined digital PCR on Life Tech's OpenArray platform with patch-clamp recording to enable exact quantification of gene expression and correlate it to phenotypic data in i

Bio-Rad executives said this week that first-quarter sales of the firm's digital PCR platform and related products increased year over year, helping to drive approximately 1 percent year-over-year and 2.5 percent sequential growth in the company's Life Science segment.